Connective Tissue Disorders and Cardiovascular Complications: The Indomitable Role of Transforming Growth Factor-β Signaling

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2021 Nov 22

PMID 34807419

Citations 6

Authors

Jason B Wheeler

John S Ikonomidis

Jeffrey A Jones

Affiliations

Soon will be listed here.

Abstract

Marfan Syndrome (MFS) and Loeys-Dietz Syndrome (LDS) represent heritable connective tissue disorders that segregate with a similar pattern of cardiovascular defects (thoracic aortic aneurysm, mitral valve prolapse/regurgitation, and aortic dilatation with regurgitation). This pattern of cardiovascular defects appears to be expressed along a spectrum of severity in many heritable connective tissue disorders and raises suspicion of a relationship between the normal development of connective tissues and the cardiovascular system. With overwhelming evidence of the involvement of aberrant Transforming Growth Factor-beta (TGF-β) signaling in MFS and LDS, this signaling pathway may represent the common link in the relationship between connective tissue disorders and their associated cardiovascular complications. To further explore this hypothetical link, this chapter will review the TGF-β signaling pathway, the heritable connective tissue syndromes related to aberrant TGF-β signaling, and will discuss the pathogenic contribution of TGF-β to these syndromes with a primary focus on the cardiovascular system.

Citing Articles

The Contribution of Mast Cells to the Regulation of Elastic Fiber Tensometry in the Skin Dermis of Children with Marfan Syndrome.

Atiakshin D, Nikolaeva E, Semyachkina A, Kostin A, Volodkin A, Morozov S Int J Mol Sci. 2024; 25(17).

PMID: 39273142 PMC: 11394836. DOI: 10.3390/ijms25179191.

MEK inhibitors: a promising targeted therapy for cardiovascular disease.

Mohammed K, Madeddu P, Avolio E Front Cardiovasc Med. 2024; 11:1404253.

PMID: 39011492 PMC: 11247000. DOI: 10.3389/fcvm.2024.1404253.

The Metabolic Syndrome, a Human Disease.

Alemany M Int J Mol Sci. 2024; 25(4).

PMID: 38396928 PMC: 10888680. DOI: 10.3390/ijms25042251.

Navigating toward gene therapy in Marfan syndrome: A hope for halting aortic aneurysm.

Egea G Mol Ther Methods Clin Dev. 2024; 32(1):101196.

PMID: 38357700 PMC: 10864845. DOI: 10.1016/j.omtm.2024.101196.

TGFβ-2 haploinsufficiency causes early death in mice with Marfan syndrome.

Sachan N, Phoon C, Zilberberg L, Kugler M, Ene T, Mintz S Matrix Biol. 2023; 121:41-55.

PMID: 37217119 PMC: 10527763. DOI: 10.1016/j.matbio.2023.05.004.

References

Annes J, Munger J, Rifkin D . Making sense of latent TGFbeta activation. J Cell Sci. 2002; 116(Pt 2):217-24. DOI: 10.1242/jcs.00229. View

Rico M, Manns J, Driban J, Uknis A, Kunapuli S, Dela Cadena R . Thrombospondin-1 and transforming growth factor beta are pro-inflammatory molecules in rheumatoid arthritis. Transl Res. 2008; 152(2):95-8. PMC: 2529228. DOI: 10.1016/j.trsl.2008.06.002. View

Loeys B, De Paepe A . New insights in the pathogenesis of aortic aneurysms. Verh K Acad Geneeskd Belg. 2008; 70(2):69-84. View

Loeys B, Schwarze U, Holm T, Callewaert B, Thomas G, Pannu H . Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006; 355(8):788-98. DOI: 10.1056/NEJMoa055695. View

Roth P, Silginer M, Goodman S, Hasenbach K, Thies S, Maurer G . Integrin control of the transforming growth factor-β pathway in glioblastoma. Brain. 2013; 136(Pt 2):564-76. DOI: 10.1093/brain/aws351. View

Wallace G, Shovlin C . A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Thorax. 2000; 55(8):685-90. PMC: 1745830. DOI: 10.1136/thorax.55.8.685. View

Park S . Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads. J Biochem Mol Biol. 2005; 38(1):9-16. DOI: 10.5483/bmbrep.2005.38.1.009. View

Zeyer K, Reinhardt D . Fibrillin-containing microfibrils are key signal relay stations for cell function. J Cell Commun Signal. 2015; 9(4):309-25. PMC: 4715827. DOI: 10.1007/s12079-015-0307-5. View

Kosaki K, Takahashi D, Udaka T, Kosaki R, Matsumoto M, Ibe S . Molecular pathology of Shprintzen-Goldberg syndrome. Am J Med Genet A. 2005; 140(1):104-8. DOI: 10.1002/ajmg.a.31006. View

10.

Mageed R, Prudhomme G . Immunopathology and the gene therapy of lupus. Gene Ther. 2003; 10(10):861-74. DOI: 10.1038/sj.gt.3302016. View

11.

Yuan X, Downing A, Knott V, Handford P . Solution structure of the transforming growth factor beta-binding protein-like module, a domain associated with matrix fibrils. EMBO J. 1998; 16(22):6659-66. PMC: 1170270. DOI: 10.1093/emboj/16.22.6659. View

12.

Seki T, Yun J, Oh S . Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res. 2003; 93(7):682-9. DOI: 10.1161/01.RES.0000095246.40391.3B. View

13.

Feng X, Derynck R . Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol. 2005; 21:659-93. DOI: 10.1146/annurev.cellbio.21.022404.142018. View

14.

Jones J, Barbour J, Stroud R, Bouges S, Stephens S, Spinale F . Altered transforming growth factor-beta signaling in a murine model of thoracic aortic aneurysm. J Vasc Res. 2008; 45(6):457-68. PMC: 2574785. DOI: 10.1159/000127437. View

15.

Lee M, Pardoux C, Hall M, Lee P, Warburton D, Qing J . TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 2007; 26(17):3957-67. PMC: 1994119. DOI: 10.1038/sj.emboj.7601818. View

16.

Droguett R, Cabello-Verrugio C, Riquelme C, Brandan E . Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biol. 2006; 25(6):332-41. DOI: 10.1016/j.matbio.2006.04.004. View

17.

Stander M, Naumann U, Wick W, Weller M . Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res. 1999; 296(2):221-7. DOI: 10.1007/s004410051283. View

18.

Wolf G, Ziyadeh F, Stahl R . Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells. J Mol Med (Berl). 1999; 77(7):556-64. DOI: 10.1007/s001099900028. View

19.

Judge D, Rouf R, Habashi J, Dietz H . Mitral valve disease in Marfan syndrome and related disorders. J Cardiovasc Transl Res. 2011; 4(6):741-7. DOI: 10.1007/s12265-011-9314-y. View

20.

Brekken R, Sage E . SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 2001; 19(8):816-27. DOI: 10.1016/s0945-053x(00)00133-5. View